Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Around three-quarters of cancer patients who have major depression do not currently receive treatment for their depression, new research led by Oxford University has found. But the researchers show that a new treatment programme is strikingly more effective at reducing depression and improving quality of life among cancer patients than current care.

The findings of the research team from the Universities of Oxford and Edinburgh are published today in three papers in the journals The Lancet Psychiatry, The Lancet and The Lancet Oncology.

Read more